Results 181 to 190 of about 1,837,575 (292)

Letter to the Editor concerning Takeda M, Koga H, Lane GJ, Tanaka N, Nagakawa Y, Okazaki T, Urao M,Yamataka A. Historical aspects of anatomic landmarks during pull-through for hirschsprung disease: focusing on resection levels of the aganglionic rectum and rectal cuff issues. Pediatr Surg Int. 2025 Nov 17;42(1):14. [PDF]

Pediatr Surg Int
Wilms M, Mohideen M, Neumayr M, Lemli A.
europepmc   +1 more source

Determinants of Variability in College Men's Sociosexuality: A Focus on Avoidance, Bros, and Masculinity Ideologies.

, 2010
Jerel P. Calzo
openalex   +1 more source

Comparative Study of Supervised Learning Algorithms for Intrusion Detection with a Focus on Logistic Regression

Owen Graham, Jane Lloris
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Self-trapping and skin solitons in two-dimensional non-Hermitian lattices. [PDF]

Commun Phys
Kokkinakis ET, Komis I, Makris KG.
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Welcoming 2026: Broadening Clinical Perspectives. [PDF]

Clin Psychopharmacol Neurosci
Pae CU.
europepmc   +1 more source

Focusing on angina [PDF]

The Lancet, 2015
openaire   +2 more sources

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Using copper-foil explosions to generate underwater focusing shocks of different geometries. [PDF]

Exp Fluids
Rojas Mata S, Hernández Garcia F, Liverts M.   +2 more
europepmc   +1 more source